Opioid Induced Constipation Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Opioid Induced Constipation Drugs Market is rising at a significant pace, projected to rise at a CAGR of 4% during the estimated period from 2021 to 2027

Opioid medications are known for suppression of gastric emptying, peristalsis of the gastrointestinal tract, and additional complications. Opioid-induced constipation can decrease quality of life, decrease work capacity, and increase access to health care facilities. Opioid-induced constipation is very common in patients suffering from cancer and non-cancer pain. Opioid-induced constipation can be prevented and treated using laxatives, stimulants, and fiber medications. This drug increases peristalsis in the gastrointestinal tract, which helps in the formation of gastric juice. In addition, these drugs increase the water content in the intestines and make stools easier to transport.

Market Segmentation:

Based on the drug types

• Methylnaltrexone Bromide
• Lubiprostone
• Naloxegol
• Naldemedine
• Docusate Sodium
• Others

Based on the prescription types

• Prescribed
• Over the Counter

Key Players

• AstraZeneca
• Cubist Pharmaceuticals (Adolor Corporation)
• Daiichi Sankyo Co. Ltd.
• Ironwood Pharmaceuticals Inc.
• Pfizer Inc.
• Progenics Pharmaceuticals Inc.
• Salix Pharmaceuticals Ltd.
• Shionogo & Co Ltd.

Scope of the Report

The research study analyzes the global Opioid Induced Constipation Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Opioid Induced Constipation Drugs Market Report

1. What was the Opioid Induced Constipation Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Opioid Induced Constipation Drugs Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Opioid Induced Constipation Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.